Skip to main content Accessibility help
×
Home
Instructions for authors

Acta Neuropsychiatrica, the official Journal of Scandinavian College of Neuropsychopharmacology, is an international journal focussing on translational neuropsychiatry. It publishes high-quality original research papers and reviews. The Journal’s scope specifically highlights the pathway from discovery to clinical applications, healthcare and global health that can be viewed broadly as the spectrum of work that marks the pathway from discovery to global health.

The steps of translation that are within the scope include: 1) fundamental discovery, 2) bench to bedside, 3) clinical trials, 4) translation to clinical guidelines, 5) health policy and usage, and 6) global health.

Research covering molecular biology, genetics, pharmacology, imaging and epidemiology is welcome as it contributes to enhancing the field.

Acta Neuropsychiatrica welcomes full-length Original Research Articles, Short Communications, Commentaries, Review Articles, Method/protocol Articles, Perspectives, and Research Letters. Debate is encouraged in the form of Letters to the Editor.

All articles published in Acta Neuropsychiatrica undergo peer review.

In submitting a manuscript to Acta Neuropsychiatrica, all authors must agree to abide by all relevant COPE policies, including its Guidelines for Responsible Conduct Regarding Scientific Communication. Manuscripts with multiple authors are reviewed with the explicit understanding that all authors have seen and approve of the submitted version and agree to abide to the policies.

POLICY ON ETHICS

It is expected that authors submitting papers to Acta Neuropsychiatrica will have conducted their work in accordance with relevant ethical standards. Procedures involving experiments on human subjects should be in accordance with the ethical standards of the Committee on Human Experimentation of the institution in which the experiments were done or in accordance with the Helsinki Declaration of 1975. Procedures involving experimentation on animals should be done in accordance with the guidelines of the country/institution in which the experiments were done.

Acta Neuropsychiatrica recognizes its responsibility to ensure that questions of scientific misconduct or dishonesty in research are adequately pursued. Should scientific misconduct or dishonesty be suspected or alleged, Acta Neuropsychiatrica follows the recommended procedures outlined by the Committee on Publication Ethics (COPE).

POLICY ON PREPUBLICATION

Acta Neuropsychiatrica does not consider manuscripts that have been previously published.

Posting to a preprint server such as bioRxiv, Authorea, Open Science Framework, etc. is not considered prior publication. Posting a manuscript to a preprint server while under review is allowed up until the point of acceptance. Abstracts, theses, posters, or manuscripts that have been posted on the Internet for the purpose of receiving commentary from the community are not considered prior publication. Online posting is typically done at a prepublication repository that has been designed for that purpose but posting on an institutional website or other Internet location is acceptable.

It is essential that any material submitted to Acta Neuropsychiatrica be original to the authors and that any copyright, license, or permission is obtained prior to submission. See Policy on Copyright for more details.

POLICY ON MOLECULAR DATA

Protein and nucleic acid sequences: Newly determined nucleotide or protein sequences must be deposited in GenBank, EMBL-EBI, or the DDBJ Center. Accession numbers must be reported in the manuscript and data must be available upon acceptance and publication of the manuscript. No data are to be withdrawn following publication.

Genomic and proteomic data: Authors of papers that include functional genomics data such as microarray, ChIP-sequencing, RNA-Seq, or other high-throughput data are required to deposit the data in a MIAME-compliant database such as GEO, ArrayExpress, or CYBEX, and to provide accession numbers. Data must be publicly accessible upon acceptance and publication of the manuscript. No data are to be withdrawn following publication.

Authors of papers that include proteomics data should comply with the guidelines developed by Molecular and Cellular Proteomics (https://www.mcponline.org/page/content/mass-spec-guidelines).

POLICY ON COMPUTER CODE AND SOFTWARE

Computational models: We recommend that new computer code be deposited in a suitable repository such as GitHub, ModelDB, BioModels, CellML, or Visiome. Studies using custom code central to the conclusions should include a statement in the Materials and Methods section, under the heading “Code Accessibility”, indicating whether the code can be accessed and how, including any accession numbers or restrictions; code should also be cited in the references. Code should be available upon acceptance and publication of the manuscript.

Software: If new software or a new algorithm is used for data analysis, authors are encouraged to deposit it in an appropriate public repository. A statement should be included in the Materials and Methods section, under the heading “Software Accessibility”, indicating whether the software or algorithm can be accessed and how, including any accession numbers or restrictions.

POLICY ON IMAGE MANIPULATION

Original data: The editors reserve the right to request any original, unprocessed data from authors at any stage in the submission, review, or publication process, including after publication. Failure to provide requested information may result in publication delays, rejection, or revocation of acceptance.

Image manipulation: All images in manuscripts accepted for publication will be screened for any indication of manipulation that is inconsistent with the following guidelines. Manipulation that violates these guidelines may result in production delays or revocation of acceptance.

  • No specific feature within an image may be enhanced, obscured, moved, removed, or introduced.
  • Constructing figures using images taken from different parts of the same gel or from different gels is discouraged. When this is necessary, it must be made explicit by the arrangement of the figure (e.g., using dividing lines) and in the text of the figure legend.
  • Recordings obtained at different time points or from different sites must not be spliced together to give the appearance of a continuous record. Authors must make it clear in the figure legend how many different recordings are illustrated.
  • Adjustments to images or recordings are acceptable if they are applied uniformly to all portions of the image or recording, and if they do not obscure, eliminate, or misrepresent information present in the original, including the background. Adjustments involving filtering or scaling (e.g., brightness, contrast, or color balance) must be applied to every pixel in the image or applied uniformly to an entire recording. Nonlinear adjustments (e.g., changes to gamma settings) or deleting portions of a recording (e.g. leak subtraction or stimulus artifacts) must be disclosed in the figure legend.
  • The minimum resolution for images is 300 dpi. Vector-format is preferred.
  • At the time of acceptance, authors will be required to submit uncropped images of complete gels for comparison to the prepared figures. If original data cannot be produced, the acceptance of the manuscript may be revoked.


POLICY CONCERNING AVAILABILITY OF MATERIALS AND DATA

Authors must agree to make freely available to colleagues in academic research any clones of cells, nucleic acids, antibodies, etc. that were used in the research reported and that are not available from commercial suppliers.

Authors should, when possible, honor requests for access to any form of published data for appropriate scientific use. The editors reserve the right to request any original data from authors at any stage in the review or publication process, including after publication. Failure to provide requested information may result in publication delays or revocation of acceptance

Submission

All manuscript submissions to Acta Neuropsychiatrica must be completed electronically through the Acta Neuropsychiatrica ScholarOne Manuscripts (formerly known as Manuscript Central) website: http://mc.manuscriptcentral.com/acn

Submissions will be considered provided that papers are previously unpublished, and are not offered simultaneously elsewhere; that all authors have read and approved the content and agree to the submission of the manuscript to the Journal.

Acta Neuropsychiatrica employs a plagiarism detection system for all submitted papers. By submitting your manuscript to this journal you accept that your manuscript will be screened for plagiarism against previously published works.

Review process

All manuscripts submitted to the journal will first be editorially reviewed by the Editor-in-Chief, who will then assign the papers to a subject-specific Associate Editor.

The authors should suggest three to five potential peer reviewers in their submission. The contact details of suggested reviewers should be institutional email addresses where possible, or contain information which will help the editor to verify the identity of the reviewer (for example ORCiD or a main reference stated in the cover letter). Should there be any non-preferred reviewers, a proper explanation must be given in the cover letter.

The Associate Editor will then assign at least two independent referees to review each paper. Based on the referee reports received along with input from the Associate Editor, the Editor-in-Chief will decide to either reject, request revisions or accept the manuscript.

Once a revised version is received, the Editors and referees will evaluate the revised manuscript. Authors will then be notified of whether their paper has been accepted or rejected for publication in the Journal.

All manuscripts accepted for publication are subject to editing by the publisher for presentation, style and grammar. The Editor-in-Chief's decision is final.

Categories of papers

Acta Neuropsychiatrica accepts the following contributions:

Original research articles

Original articles report the results of original research and are intended for full- scale basic or clinical studies including large controlled trials. Translational work is encouraged, but not required. Original articles should not exceed 6,500 words

(not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered for unusually large or complex studies).

Short communications

This category is for 'fast-breaking' new work, which is of great potential interest and can be succinctly presented. Papers in this category may contain up to 2,500 words (not including references, figures and tables) and should include a maximum of 25 references, up to 2 illustrations (figures or tables), an abstract of up to 150 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search).

Commentaries

Commentaries focus attention on scientific issues in the field of the journal, and should highlight, discuss and amplify these issues. Commentaries may contain up to 5,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). Commentaries are invited by the Editor-in-Chief.

Method/Protocol articles

Acta Neuropsychiatrica will publish a limited number of Method/Protocol articles, which focus on protocols and on novel methods providing significant improvements and extensions to already established research areas. Method/Protocol articles may be invited by the Editors but can also be submitted. Method/Protocol articles may contain up to 6,000 words (not including refs, figs and tables) and should include an abstract of up to 250 words. and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered if justified by the scope of the paper).

Review articles

Acta Neuropsychiatrica will publish a limited number of scholarly, comprehensive reviews that summarize and critically evaluate research in the field addressed and identify future implications. Reviews may be invited by the Editors but can also be submitted. Reviews may contain up to 10,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered if justified by the scope of the Review).

Perspectives articles

Acta Neuropsychiatrica will publish a limited number of Perspective articles that critically perspective research in the field addressed and describe future potentials. Perspectives may be invited by the Editors but can also be submitted. Perspectives may contain up to 10,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search).  (Exceptions to the length limitation will be considered if justified by the scope of the Perspectives).

Protocol articles

Acta Neuropsychiatrica will publish a limited number of Method/Protocol articles, which focus on protocols and on novel methods providing significant improvements and extensions to already established research areas.  Method/Protocol articles may be invited by the Editors but can also be submitted. Method/Protocol articles may contain up to 6,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). 

Debate papers

Letters to the Editor are welcomed to the Acta Neuropsychiatrica debate section, especially if they relate to ongoing debates or comment on recent publications in the Journal. A maximum of 5 references can be included in papers published in the Debate Section.

Research letters

Acta Neuropsychiatrica welcomes submissions of Research Letters, which represent an opportunity to publish (preliminary) research findings that are of interest to the field. Research Letters are “unstructured”, i.e. without the subheadings used in the full-length manuscripts. The length of the letters should be approximately 750-1000 words and a maximum of 5 references can be included. The authors may include a small table or figure in the submission. Abstracts are not used for Research Letters.

Papers in all categories, whether invited or submitted, will be peer reviewed.

Manuscript style

Consult a current issue of the Journal for style and format. The manuscript should be typed double-spaced throughout on 'Letter' or A4 paper. Pages should be numbered sequentially beginning with the Title Page. Margins should not be less than 2.5 cm on all sides, and the font should be clearly legible and uniform throughout.

Title page (Page 1)

All manuscripts should contain a concise, informative title (max 15 words; abbreviations, acronyms, colon, semicolon or the like are not allowed), the authors' names, the names in English of departments and institutions to be attributed, and their city and country of location. Please also include a running title with a maximum of 50 characters (letters and spaces). Name, telephone number, fax number, e-mail address and full postal address of the corresponding author should be stated.

Abstract and keywords (Page 2)

Abstract not exceeding 250 words (150 for short communications) with the following structure:

Objective: State the objective of the study and the main hypothesis tested in the second sentence.

Methods: Describe the basic design of the study as well as its setting, participants and key measurements or outcomes. Describe, if appropriate, the essential features of any interventions, including their method and duration of administration. For systematic reviews, list the data sources used, including time restrictions and search terms. Provide the number of studies reviewed and the selection criteria.

Results: Provide data for the key measurements in this section. Give confidence intervals for differences where appropriate or other measures of statistical significance. All data in the abstract must be reported in the text of the paper as well.

Conclusion: Briefly summarise the main findings and potential application. A consideration of the significance of the study and recommendations for further work should appear in the main text, not the abstract.

The main part of the Abstract should be devoted to Results.

5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search)

For Original Articles and Short Communications specifically

Significant Outcomes

Provide up to 3 Significant Outcomes encapsulating the 'take-home messages' of the article, and identify the main issues addressed with particular emphasis on the scientific significance. The Significant Outcomes are to be presented succinctly (1 max 2 sentences each), in tabulated form, and logically emerge from the conclusions of the paper (without repeating). However, they must not be dogmatic, raise new issues or pose further questions.

Limitations

In addition, each original article must cite up to 3 noteworthy Limitations. These should inform the reader about potential weaknesses, for instance in aspects of study design, methodology, analyses, the wider generalizability, or the wider application of findings.

The Significant Outcomes and the Limitations are placed immediately below the Abstract/Keywords.

For Review Articles specifically

Summations

Provide up to 3 significant Summations encapsulating the 'take-home messages' of the paper, and identify the main issues addressed with particular emphasis on their clinical and/or scientific significance. The Summations should be presented succinctly (1 max 2 sentences each), in tabulated form, and logically emerge from the conclusions of the paper (without repeating). However, they must not be dogmatic, raise new issues or pose further questions.

Considerations

In addition, each review article must cite up to 3 noteworthy Considerations in which authors essentially criticise the summations and include any caveats or limitations either of the review process or its conclusions.

The Summations and Considerations are placed immediately below the Abstract/Keywords.

For Perspectives/Method/Protocols articles specifically:

Summations

Provide up to 3 significant Summations encapsulating the 'take-home messages' of the paper, and identify the main issues addressed with particular emphasis on their clinical and/or scientific significance. The Summations should be presented succinctly (1 max 2 sentences each), in tabulated form, and logically emerge from the conclusions of the paper (without repeating). However, they must not be dogmatic, raise new issues or pose further questions.

Perspectives

In addition, each perspective article must cite up to 3 noteworthy perspectives in which authors essentially criticise the summations and include any caveats or limitations either of the perspective or its conclusions. The Summations and Perspectives are placed immediately below the Abstract/Keywords.

Manuscript body (from page 3) – Review articles

Authors are required to base the manuscript on the structure outlined in the PRISMA checklist: 

http://www.prisma-statement.org/PRISMAStatement/Checklist.aspx

Manuscript body (from page 3) – Commentaries and Letter to the editor

No specific structure is required for the manuscript body in these categories.

Manuscript body (from page 3) – Original Research Articles, Short Communications and Perspectives

Introduction

One to two pages, providing an appropriate background to the article, drawing on relevant literature and explaining the research question to be addressed. The introduction should be concluded by the subtitle Aims of the Study (3 to 5 lines without literature references and abbreviations).

Material and methods

It should be possible to read every article by itself. The author cannot refer to design, method and material described in previously published articles. This section should demonstrate a clear and documented design or strategy directed towards a specific research question. The study design should be appropriate to the aims of the study and be clearly described. The criteria for selecting the sample should be clearly described and justified. A clear description of sampling, recruitment to the study, data collection, and data analysis should be provided. Full details of interventions should be given for intervention studies. The authors should use metric units and the generic names of drugs throughout the manuscript. Laboratory units must be followed by SI (System International) units.

Specifically for animal studies, a supplementary file (based on this journal template) containing detailed experimental information according to the ARRIVE guidelines (https://doi.org/10.1371/journal.pbio.1000412) must be included.

Results

Clear and short avoiding double documentation to tables/figures. The results section be clear and short, containing all the information required to assess the validity of the conclusions. Double documentation to tables/figures should be avoided, but the characteristics of the sample included in the study should be clearly described. Any analyses should be clear and systematic. Results of statistical tests should be reported with confidence intervals in order to provide an estimate of precision. All tables or figures must be referred to by name in the text.

Discussion

A structured discussion covering but not limited to the following sections should be included; summary of main findings; the strengths and the limitations of this study; relevance to the existing literature, and the implications for future research or clinical practice. Acta Neuropsychiatrica articles do not have a conclusion section. If the authors find it necessary, they may include a concluding remark of maximum 5 lines as the final part of the Discussion.

Authors Contributions

It is a requirement that the corresponding author submits a short description of each individual's contribution to the research and its publication. Acta Neuropsychiatrica adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

Acknowledgements

You may acknowledge individuals or organisations that provided advice, support (non-financial). Formal financial support and funding should be listed in the following section.

Financial support

Please provide details of the sources of financial support for all authors, including grant numbers. For example, “This work was supported by the Medical research Council (grant number XXXXXXX)”. Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with “and” before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors’ initials. For example, “This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)”. Where no specific funding has been provided for research, please provide the following statement: “This research received no specific grant from any funding agency, commercial or not-for-profit sectors.”

Statement of interest

Please provide details of all known financial, professional and personal relationships with the potential to bias the work. Please list the nature of any financial links with manufacturers of any of the materials or devices described in the manuscript. This includes relevant past as well as relevant present consultancy with the pharmaceutical industry or regulatory agency. Industry based authors please acknowledge whether or not you are employed by a company that sells one or more of the drugs or devices mentioned in your article.

Where no known conflicts of interest exist, please include the following statement: “None.”

Animal Welfare

An Animal Welfare Ethical Statement must be included for all studies involving animals. Furthermore, a supplementary file containing detailed experimental information according to the ARRIVE guidelines (https://doi.org/10.1371/journal.pbio.1000412) must be included. Please use this journal template: https://www.cambridge.org/core/services/aop-file-manager/file/59cab787f3763e390626d8ed.

Ethical standards

Where research involves human and/or animal experimentation, the following statements should be included (as applicable): “The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.” and “The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals.”

Figure Legends (see also below)

Legends should be provided for each Figure on a separate sheet in the manuscript.

Reference list (start on a separate page)

Use the Harvard (author-date) system (see below). We recommend the use of a reference management tool.

Tables and figures

A maximum of 7 tables/figures can be included (2 for short communication). Figures are given priority. Tables and figures should be included on separate sheets, and numbered in order of their mention in the text with Arabic numerals and should include a brief, self-explanatory, descriptive title. Scale bars should be added to photomicrographs and other similar images.

Legends should be provided for each Figure on a separate sheet in the manuscript. A separate image file of each figure is required. Ensure that figures will be legible and comprehensible at final size and are of sufficiently high resolution.

Figures should be supplied (permitted file formats are TIFF (.tif), JPEG (.jpg) EPS (.eps), and PDF (.pdf)) where possible at approximately the size in which they are to reproduce. Line artwork should be supplied in black and white mode at a resolution of 1200 dpi; combination artwork (line/tone) at a resolution of 800 dpi; black and white halftone artwork should be saved in ‘grayscale’ mode at a resolution of 300dpi; color halftone artwork should be saved in CMYK mode at a resolution of 400 dpi. Tables should be double-spaced, no wider than 120 typewriter characters (including spaces).  Please refer to our Journals Artwork Guide for additional information on preparing and submitting artwork.

All figures/tables should clarify the text and their number be kept to a minimum and not exceed 7 in total. Avoid data overload. Details must be large enough to retain their clarity after reduction in size. Illustrations should be planned to fit the proportions of the printed page. Colour illustrations are welcomed.

There will no cost to authors for the publication of colour images in the online- only edition journals.

Abbreviations and symbols

For abbreviations and symbols use Units, Symbols and Abbreviations for Authors and Editors in Medicine Related Sciences, Sixth Edition. Edited by D.N. Baron and M McKenzie Clarke. ISBN: 9781853156243, Paperback, April, 2008. All terms or abbreviations should be fully explained at first mention. All units should be metric. Use no Roman numerals. Abbreviations are not allowed in titles, headings and "Aims of the Study".

References (start on new page)

1).  The Harvard (author-date) system should be used in the text and a complete list of References cited given at the end of the article. In a text citation of a work by more than two authors cite the first author's name followed by et al. (but the names of all of the authors should be given in the References section). Where several references are cited together they should be listed in rising date order.

2).  The References section should be in alphabetical order. Examples follow:

Brown GW (1974). Meaning, measurement and stress of life events. In Stressful Life Events: Their Nature and Effects (ed. B. S. Dohrenwend and B. P. Dohrenwend), pp. 217-244. John Wiley: New York.

Brown J. (1970). Psychiatric Research. Smith: Glasgow.

Leonard, BE (2018b). Inflammation and depression: A causal or coincidental link to the pathophysiology? Acta Neuropsychiatrica 30(1), 1-16.

Note: authors' names should be in bold font; journal titles should always be given in full.

3). References to material published online should follow a similar style, with the URL included at the end of the reference, with the accession date, if known. Authors are requested to print out and keep a copy of any online-only information, in case the URL changes or is no longer maintained. Examples follow:

National Center for Injury Prevention and Control. (http://www.cdc.gov/ncipc/profiles/acutecare/default.htm). Accessed 7 June 2004.

British Psychological Society Research Digest, Issue 12. (http://lists.bps.org.uk/read/messages?id=1423). Accessed 17 February 2004.

Abstracts cannot be used as references, unless published in an indexed scientific journal. Include manuscripts accepted, but not published; designate the abbreviated title of the journal followed by (in press). Papers published electronically, not yet hard copy publication should be identified by their DOI-number. Information from manuscripts not yet accepted should be cited in the text as personal communication. References must be verified by the authors against the original documents. Titles of journals should be abbreviated in accordance with MEDLINE  
(https://www.ncbi.nlm.nih.gov/nlmcatalog/journals).

Neuroscience-based Nomenclature

For papers concerning neuropsychopharmacological treatments, Acta Neuropsychiatrica encourages authors to utilize the ‘Neuroscience-based Nomenclature’ developed by the ECNP Taskforce on Nomenclature. The need for such a change arose to address a longstanding concern within the neuropsychopharmacological community that the nomenclature of psychotropic drugs did not properly reflect the underlying neuroscience of these compounds, as well as being unhelpful to clinicians and confusing to patients (e.g. the prescription of ‘antipsychotics’ for depression).

More information about the nomenclature can be found on the ECNP website here, and in the paper here. The Neuroscience-based Nomenclature (NbN) itself is available free of charge as a mobile app (for both Android and iOS devices).

Open Access

Under the conditions detailed on the Journal’s standard transfer of copyright form, when an article is accepted, its authors are free to post their version of the accepted manuscript on a website or repository. As such, the Journal is compliant with the ‘Open Access’ mandates of the vast majority of academic institutions and funding sources.

Authors also have the option to publish their paper under a fully ‘Open Access’ agreement, upon the payment of a one-off ‘Article Processing Charge’.

In this case, the final published ‘Version of Record’ shall be made freely available to all, in perpetuity, and will be published under a creative commons licence, enabling its free re-use and redistribution for non-commercial means. Click here for the open access transfer of copyright form. The corresponding author will be able to choose between standard publication and publication under the ‘Open Access’ agreement once their paper has been accepted.

More information about Open Access, including the current Article Processing Charge, can be found on our website.

Author Language Services

Cambridge recommends that authors have their manuscripts checked by an English language native speaker before submission; this will ensure that submissions are judged at peer review exclusively on academic merit. We list a number of third-party services specialising in language editing and / or translation, and suggest that authors contact as appropriate. Use of any of these services is voluntary, and at the author's own expense.

ORCID

Acta Neuropsychiatrica now requires that all corresponding authors identify themselves using their ORCID iD when submitting a manuscript to the journal. ORCID provides a unique identifier for researchers and, through integration in key research workflows such as manuscript submission and grant applications, provides the following benefits:

  • Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you’ve authored.
  • Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
  • Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.


If you don’t already have an iD, you’ll need to create one if you decide to submit a manuscript to Acta Neuropsychiatrica. You can register for one directly from your user account on Scholar One or via https://ORCID.org/register. If you already have an iD, please use this when submitting, either by linking it to your Scholar One account or supplying it during submission by using the “Associate your existing ORCID ID” button.

Last updated 12th August 2019